BioCentury
ARTICLE | Clinical News

Neublastin artemin/enovin: Phase I data

June 18, 2012 7:00 AM UTC

A single-blind, placebo-controlled, Australian Phase I trial in 44 sciatic patients showed that single doses of IV Neublastin were well tolerated with no treatment-related serious adverse events repor...